Forecast: Import of Heparin for Therapeutic Use to the US

The import of Heparin for therapeutic use to the US is expected to follow a gradual upward trend over the next five years. From 2024 to 2028, the forecast showcases a steady increase in imports from $457.77 million in 2024 to $482.41 million in 2028. This reflects a compound annual growth rate (CAGR) of approximately 1.32% over the period. If 2023 is considered as the base year, imports likely lay significantly lower, indicating positive market growth spurred by rising demand for anticoagulants.

Future trends to watch for include:

• Increasing aging population and related medical needs potentially driving up demand for Heparin.
• Advancements in biotechnology that may influence production costs and import volume.
• Potential regulatory changes affecting the pharmaceutical import landscape.